BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30479196)

  • 1. Lessons Learned from Using Global Outcome Measures to Assess Community Pharmacy Performance.
    Urick BY; Ferreri SP; Shasky C; Pfeiffenberger T; Trygstad T; Farley JF
    J Manag Care Spec Pharm; 2018 Dec; 24(12):1278-1283. PubMed ID: 30479196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Medication Adherence Among Pharmacies Participating in a North Carolina Enhanced Services Network.
    Urick BY; Bhosle M; Farley JF
    J Manag Care Spec Pharm; 2020 Jun; 26(6):718-722. PubMed ID: 32463769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telehealth medication management and health care spending in a Medicare Accountable Care Organization.
    Urick BY; Peters A; Pathak S; Vest MH; Colmenares E; Blanchard C; Easter J; Foushee L; DeFalco P
    J Manag Care Spec Pharm; 2023 Apr; 29(4):357-364. PubMed ID: 36989448
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacy characteristics correlating to performance in a community pharmacy network.
    Renfro CP; Urick BY; Mansour MA; Ferreri SP
    J Am Pharm Assoc (2003); 2019; 59(2):275-279. PubMed ID: 30827530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing an integrated care management program in community pharmacies: A focus on medication management services.
    Smith MG; Ferreri SP; Brown P; Wines K; Shea CM; Pfeiffenberger TM
    J Am Pharm Assoc (2003); 2017; 57(2):229-235.e1. PubMed ID: 28173993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
    Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
    J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do enhanced services pharmacies serve sicker patients?
    Urick BY; Farley JF
    J Am Pharm Assoc (2003); 2019; 59(2):280-284. PubMed ID: 30713081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial Sustainability of an Oregon Rural Health, Primary Care, and Pharmacist-Run Comprehensive Medication Management Program Through Direct Medical Billing.
    Hoover ND; Turner RB; Sampson J; Pye T; Hotan T
    J Manag Care Spec Pharm; 2020 Jan; 26(1):30-34. PubMed ID: 31880232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between pharmacy choice and influenza vaccination: Mail order vs community pharmacy users.
    Burbage SC; Parikh MA; Campbell PJ; Ramachandran S; Gatwood J; Ozawa S; Urick BY
    J Manag Care Spec Pharm; 2022 Dec; 28(12):1379-1391. PubMed ID: 36427345
    [No Abstract]   [Full Text] [Related]  

  • 11. Performance-based pharmacy payment models: key components and critical implementation considerations for successful uptake and integration.
    Richard C; Urick BY; Pathak S; Jackson J; Livet M
    J Manag Care Spec Pharm; 2021 Nov; 27(11):1568-1578. PubMed ID: 34714107
    [No Abstract]   [Full Text] [Related]  

  • 12. Store and prescription characteristics associated with primary medication nonadherence.
    Jackson TH; Bentley JP; McCaffrey DJ; Pace P; Holmes E; West-Strum D
    J Manag Care Spec Pharm; 2014 Aug; 20(8):824-32. PubMed ID: 25062076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality-driven pharmacy and medication therapy management services.
    Trapskin K; Johnson C; Cory P; Sorum S; Decker C
    J Am Pharm Assoc (2003); 2009; 49(5):642-51. PubMed ID: 19748873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and effect of performance-based pharmacy payment models.
    Urick BY; Pathak S; Hughes TD; Ferreri SP
    J Manag Care Spec Pharm; 2021 Mar; 27(3):306-315. PubMed ID: 33645246
    [No Abstract]   [Full Text] [Related]  

  • 15. Strategies for community-based medication management services in value-based health plans.
    Smith MA; Spiggle S; McConnell B
    Res Social Adm Pharm; 2017; 13(1):48-62. PubMed ID: 26904962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community pharmacists' perceptions of acceptability, appropriateness, and feasibility of a value-based care model for comprehensive medication management.
    Pestka DL; Stoa MK; Sorensen TD; Blanchard CM
    J Manag Care Spec Pharm; 2021 Jul; 27(7):865-872. PubMed ID: 34185558
    [No Abstract]   [Full Text] [Related]  

  • 17. Estimated Potential Financial Impact of Pharmacist-Delivered Disease Management Services Across a Network of Pharmacies in Rural Colorado.
    Nuffer W; Trujillo T; Griend JV
    J Manag Care Spec Pharm; 2019 Sep; 25(9):984-988. PubMed ID: 31456492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analysis of community pharmacists' recommendations in the North Carolina Medicaid medication therapy management program.
    Michaels NM; Jenkins GF; Pruss DL; Heidrick JE; Ferreri SP
    J Am Pharm Assoc (2003); 2010; 50(3):347-53. PubMed ID: 20452907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacy participation and claim characteristics in the Wisconsin Medicaid Pharmaceutical Care Program from 1996 to 2007.
    Look KA; Mott DA; Leedham RK; Kreling DH; Hermansen-Kobulnicky CJ
    J Manag Care Pharm; 2012 Mar; 18(2):116-28. PubMed ID: 22380471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a Virtual Pharmacy Review Program: A Population Health Case Study.
    Muraywid B; Butkievich LE; Myers B
    J Manag Care Spec Pharm; 2020 Jan; 26(1):24-29. PubMed ID: 31880223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.